NCT03259282

Brief Summary

Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in a retrospective cohort of patients at Rennes University Hospital

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2017

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 23, 2017

Completed
Last Updated

April 12, 2018

Status Verified

April 1, 2018

Enrollment Period

15 days

First QC Date

August 21, 2017

Last Update Submit

April 10, 2018

Conditions

Sarcoidosis

Outcome Measures

Primary Outcomes (2)

  • Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on disease activity

    Electrophoresis rates of serum proteins

    Day 1

  • Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on the course of the disease

    Electrophoresis rates of serum proteins

    Day 1

Interventions

Analysis of gamma globulinBIOLOGICAL

Electrophoresis of proteins

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with sarcoidosis

You may qualify if:

  • \- Patients newly diagnosed with sarcoidosis

You may not qualify if:

  • Comorbidity responsible for a change in the level of gamma globulin
  • Other etiology of granulomatosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35033, France

Location

MeSH Terms

Conditions

Sarcoidosis

Condition Hierarchy (Ancestors)

Lymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesHypersensitivity, DelayedHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2017

First Posted

August 23, 2017

Study Start

March 7, 2017

Primary Completion

March 22, 2017

Study Completion

March 22, 2017

Last Updated

April 12, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)